Zoonotic Disease Treatment Market Size Forecast: Revenue and CAGR by 2029

November 12, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Zoonotic Disease Treatment Industry In 2025?

The zoonotic disease treatment market size has experienced significant growth in recent years. It is anticipated to increase from $39.71 billion in 2024 to $42.51 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.0%. This historical expansion can be attributed to the emergence of major zoonotic outbreaks, urbanization, and habitat encroachment, the implementation of a one health approach, enhanced surveillance and reporting, globalization, increased travel, and greater public awareness and education.

The zoonotic disease treatment market size is anticipated to undergo significant expansion in the next few years. It is projected to reach $54.84 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 6.6%. This growth during the forecast period is expected due to climate change and environmental factors, government and international funding, advancements in medical technology, regulatory support and streamlined approvals, and collaborative research and development. Key trends identified for this period include the development of broad-spectrum antivirals, a strengthening of global health infrastructure, advances in diagnostic technology, growth in vaccine development platforms, and an increased focus on preventive measures.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15965&type=smp

Which Drivers Are Shaping The Zoonotic Disease Treatment Industry’s Market Share?

The escalating need for animal proteins is projected to drive the expansion of the zoonotic disease treatment market. Animal proteins, sourced from items such as meat, dairy, eggs, and fish, supply all essential amino acids for human health. This amplified demand for animal proteins results from an expanding global population, increased income levels, growing urbanization, and a heightened awareness of the nutritional benefits offered by animal-based foods. Zoonotic disease treatments provide critical insights for addressing illnesses originating from animal proteins, understanding transmission pathways, formulating effective therapies, and implementing preventative measures to lessen public health hazards. For instance, in July 2023, a report published by the Organization for Economic Co-operation and Development and the Food and Agriculture Organization, a US-based agricultural commodity market, indicated that global meat consumption is expected to rise at an annual rate of 0.1%. This increment is primarily fueled by increasing demand in middle and lower-income countries, with poultry anticipated to constitute nearly half of the total growth in meat production by 2032. Consequently, the rising demand for animal proteins is propelling the growth of the zoonotic disease treatment market.

What Are The Key Segments In The Zoonotic Disease Treatment Market?

The zoonotic disease treatment market covered in this report is segmented –

1) By Disease Type: Rabies, Tuberculosis, Malaria, Leishmaniasis, Ebola Virus Disease, Other Disease Types

2) By Drug Class: Anti-Fungal, Anti-Bacterial, Antibiotics, Other Drug Classes

3) By Causative Agent: Bacteria, Virus, Nematode, Rodents, Ticks, Other Causative Agents

4) By Route Of Administration: Oral, Topical, Other Routes Of Administrations

5) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

Subsegments:

1) By Rabies: Post Exposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)

2) By Tuberculosis: Latent Tuberculosis Treatment, Active Tuberculosis Treatment

3) By Malaria: Plasmodium falciparum Malaria, Plasmodium Vivax Malaria, Other Malaria Types

4) By Leishmaniasis: Visceral Leishmaniasis, Cutaneous Leishmaniasis, Mucocutaneous Leishmaniasis

5) By Ebola Virus Disease: Pre-Exposure Vaccination, Post-Exposure Treatment

6) By Other Disease Types: Zika Virus, Lassa Fever, Yellow Fever, Chikungunya

What Are The Latest Industry Trends Transforming The Zoonotic Disease Treatment Market?

Leading companies operating in the zoonotic disease treatment market are prioritizing investments in zoonotic disease treatment to improve diagnostic capabilities and refine treatment protocols. This entails developing advanced diagnostic technologies, such as PCR kits, to enable more rapid identification of zoonotic pathogens, alongside implementing targeted therapeutic interventions. For instance, in October 2023, BioPerfectus, a China-based biotechnology company specializing in diagnostic solutions, introduced thirteen new additions to its Zoonotic Infectious Diseases Total PCR Solution. This enhancement is designed to strengthen its diagnostic capabilities for zoonotic diseases, which comprise over 60% of known infectious diseases and 75% of emerging infections. The initiative aims to bolster health security preparedness and response, especially as climate change accelerates the spread of infectious diseases to new regions. With these new products, the company seeks to facilitate quicker diagnoses and better management of zoonotic infections, underscoring the importance of proactive public health measures.

Which Leading Players Are Enhancing Their Zoonotic Disease Treatment Market Presence Worldwide?

Major companies operating in the zoonotic disease treatment market are Pfizer Inc., Johnson & Johnson Services Inc., Merck And Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis International AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Zoetis Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, IDEXX Laboretories Inc., Hikma Pharmaceuticals PLC., Ceva Santé Animale, Vir Biotechnology Inc., Virbac, Vetoquinol S.A., BioCryst Pharmaceuticals Inc., Heska Corporation

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/zoonotic-disease-treatment-global-market-report

Which Region Currently Holds The Largest Share Of The Zoonotic Disease Treatment Market?

North America was the largest region in the zoonotic disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the zoonotic disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Zoonotic Disease Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15965&type=smp

Browse Through More Reports Similar to the Global Zoonotic Disease Treatment Market 2025, By The Business Research Company

Merkel Cell Carcinoma Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/merkel-cell-carcinoma-treatment-global-market-report

Basal Cell Carcinoma Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/basal-cell-carcinoma-treatment-global-market-report

Crohns Disease Cd Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/crohns-disease-cd-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795